Genotype and phenotype of allospecific T-cell clones from WAS 995C>T patient
Genotype (WT CGA-Arg) . | No. of clones carrying specified genotype . | WASp expression +/− . | Present in primary cells*CD3 . | ||||||
---|---|---|---|---|---|---|---|---|---|
First blood draw . | Second blood draw . | ||||||||
CD4† . | CD8‡ . | ND . | Total . | % of total . | Total . | % of total . | |||
995C>T germline mutation (Stop) | 112§ | 8 | 15 | 135 | 50.6 | 69 | 50.0 | − | + |
% CD4 or CD8 clones with germline mutation | 65 | 18 | |||||||
Class I | |||||||||
995C>T>A (Arg) | 33 | 6 | 15 | 54 | 20.2 | 31 | 22.5 | + | + |
995C>T>C (Wt-Arg) | 0 | 0 | 2 | 2 | 0.7 | 0 | 0.0 | ND | + |
995C>T>G (Gly) | 3 | 1 | 3 | 7 | 2.6 | 3 | 2.2 | + | + |
995C>T, 996G>C (Ser) | 9 | 8 | 3 | 20 | 7.5 | 7 | 5.1 | + | + |
995C>T, 996G>T (Leu) | 0 | 0 | 0 | 1∥ | 0.4 | 0 | 0.0 | + | + |
995C>T, 997A>C (Cys) | 0 | 3 | 0 | 3 | 1.1 | 0 | 0.0 | + | + |
CD4 or CD8 clones with class I genotype, % | 26 | 40 | |||||||
Total class I | 86 | 32.2 | 41 | 29.7 | |||||
Class II | |||||||||
995C>T, IVS9 −1G>A | 0 | 5 | 3 | 8 | 3.0 | 3 | 2.2 | + | + |
995C>T, IVS9 −2A>C | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −2A>G | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −3C>G | 1 | 11 | 2 | 14 | 5.2 | 4 | 2.9 | + | + |
995C>T, IVS9 −3C>T | 1 | 0 | 0 | 1 | 0.4 | 3 | 2.2 | + | + |
995C>T, IVS9 −6C>G | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −7T>G | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | + |
995C>T, IVS9 −7T>A | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | + | − |
995C>T, IVS9 −12C>G | 2 | 0 | 0 | 2 | 0.7 | 2 | 1.4 | + | + |
995C>T, IVS9 −24C>G | 2 | 0 | 0 | 2 | 0.7 | 3 | 2.2 | + (weak) | + |
995C>T, IVS9 −27C>G | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
995C>T, IVS9 −84G>C | 0 | 0.0 | 1 | 0.7 | + (weak) | + | |||
CD4 or CD8 clones with class II genotype, % | 5 | 36 | |||||||
Total class II | 30 | 11.2 | 20 | 14.5 | |||||
Class III | |||||||||
995C>T, 988G>T | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, 999G>C | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
995C>T, 1007C>T | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | + | − |
995C>T, 1095C>T | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | + |
995C>T, 1109C>T, 1110C>T | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | ND | − |
995C>T, 1124C>T | 0 | 0 | 1 | 1 | 0.4 | 2 | 1.4 | + (weak) | + |
995C>T, 1155C>G | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
CD4 or CD8 clones with class III genotype, % | 2 | 0 | |||||||
Total class III | 5 | 1.9 | 5 | 3.6 | |||||
Class IV | |||||||||
995C>T, del IVS9 −84 to −21 (64 bp) | 0 | 1 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
995C>T, del IVS9 −32 to −18 (15 bp) | 0 | 0.0 | 2 | 1.4 | + | − | |||
del IVS9 −74 to exon 10 1045 (154 bp) | 0 | 1 | 0 | 1 | 0.4 | 0 | 0.0 | + | + |
del exon 10 968 to 1057 (90 bp, 30 aa) | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | − |
995C>T, del exon 10 976 to 991 (16 bp) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
del exon 10 984 to 1028 (45 bp, 15 aa) | 0 | 1 | 1 | 2 | 0.7 | 1 | 0.7 | + | − |
del exon 10 988 to 1050 (63 bp, 21 aa) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | ND | − |
del exon 10 992 to 997 (6 bp, 2 aa) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
995C>T, del exon 10 996 to 998 (3 bp) | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | ND | − |
CD4 or CD8 clones with class IV genotype, % | 3 | 7 | |||||||
Total class IV | 10 | 3.7 | 3 | 2.2 | |||||
Total no. of clones | 173 | 45 | 48 | 267 | 100.0 | 138 | 100.0 | ||
CD4 or CD8 clones, % | 65 | 17 |
Genotype (WT CGA-Arg) . | No. of clones carrying specified genotype . | WASp expression +/− . | Present in primary cells*CD3 . | ||||||
---|---|---|---|---|---|---|---|---|---|
First blood draw . | Second blood draw . | ||||||||
CD4† . | CD8‡ . | ND . | Total . | % of total . | Total . | % of total . | |||
995C>T germline mutation (Stop) | 112§ | 8 | 15 | 135 | 50.6 | 69 | 50.0 | − | + |
% CD4 or CD8 clones with germline mutation | 65 | 18 | |||||||
Class I | |||||||||
995C>T>A (Arg) | 33 | 6 | 15 | 54 | 20.2 | 31 | 22.5 | + | + |
995C>T>C (Wt-Arg) | 0 | 0 | 2 | 2 | 0.7 | 0 | 0.0 | ND | + |
995C>T>G (Gly) | 3 | 1 | 3 | 7 | 2.6 | 3 | 2.2 | + | + |
995C>T, 996G>C (Ser) | 9 | 8 | 3 | 20 | 7.5 | 7 | 5.1 | + | + |
995C>T, 996G>T (Leu) | 0 | 0 | 0 | 1∥ | 0.4 | 0 | 0.0 | + | + |
995C>T, 997A>C (Cys) | 0 | 3 | 0 | 3 | 1.1 | 0 | 0.0 | + | + |
CD4 or CD8 clones with class I genotype, % | 26 | 40 | |||||||
Total class I | 86 | 32.2 | 41 | 29.7 | |||||
Class II | |||||||||
995C>T, IVS9 −1G>A | 0 | 5 | 3 | 8 | 3.0 | 3 | 2.2 | + | + |
995C>T, IVS9 −2A>C | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −2A>G | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −3C>G | 1 | 11 | 2 | 14 | 5.2 | 4 | 2.9 | + | + |
995C>T, IVS9 −3C>T | 1 | 0 | 0 | 1 | 0.4 | 3 | 2.2 | + | + |
995C>T, IVS9 −6C>G | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, IVS9 −7T>G | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | + |
995C>T, IVS9 −7T>A | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | + | − |
995C>T, IVS9 −12C>G | 2 | 0 | 0 | 2 | 0.7 | 2 | 1.4 | + | + |
995C>T, IVS9 −24C>G | 2 | 0 | 0 | 2 | 0.7 | 3 | 2.2 | + (weak) | + |
995C>T, IVS9 −27C>G | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
995C>T, IVS9 −84G>C | 0 | 0.0 | 1 | 0.7 | + (weak) | + | |||
CD4 or CD8 clones with class II genotype, % | 5 | 36 | |||||||
Total class II | 30 | 11.2 | 20 | 14.5 | |||||
Class III | |||||||||
995C>T, 988G>T | 0 | 0.0 | 1 | 0.7 | + | − | |||
995C>T, 999G>C | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
995C>T, 1007C>T | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | + | − |
995C>T, 1095C>T | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | + |
995C>T, 1109C>T, 1110C>T | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | ND | − |
995C>T, 1124C>T | 0 | 0 | 1 | 1 | 0.4 | 2 | 1.4 | + (weak) | + |
995C>T, 1155C>G | 0 | 0.0 | 1 | 0.7 | + (weak) | − | |||
CD4 or CD8 clones with class III genotype, % | 2 | 0 | |||||||
Total class III | 5 | 1.9 | 5 | 3.6 | |||||
Class IV | |||||||||
995C>T, del IVS9 −84 to −21 (64 bp) | 0 | 1 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
995C>T, del IVS9 −32 to −18 (15 bp) | 0 | 0.0 | 2 | 1.4 | + | − | |||
del IVS9 −74 to exon 10 1045 (154 bp) | 0 | 1 | 0 | 1 | 0.4 | 0 | 0.0 | + | + |
del exon 10 968 to 1057 (90 bp, 30 aa) | 0 | 0 | 1 | 1 | 0.4 | 0 | 0.0 | ND | − |
995C>T, del exon 10 976 to 991 (16 bp) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
del exon 10 984 to 1028 (45 bp, 15 aa) | 0 | 1 | 1 | 2 | 0.7 | 1 | 0.7 | + | − |
del exon 10 988 to 1050 (63 bp, 21 aa) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | ND | − |
del exon 10 992 to 997 (6 bp, 2 aa) | 1 | 0 | 0 | 1 | 0.4 | 0 | 0.0 | + | − |
995C>T, del exon 10 996 to 998 (3 bp) | 2 | 0 | 0 | 2 | 0.7 | 0 | 0.0 | ND | − |
CD4 or CD8 clones with class IV genotype, % | 3 | 7 | |||||||
Total class IV | 10 | 3.7 | 3 | 2.2 | |||||
Total no. of clones | 173 | 45 | 48 | 267 | 100.0 | 138 | 100.0 | ||
CD4 or CD8 clones, % | 65 | 17 |
ND indicates not determined.
Indicates whether genotype, first identified in allospecific T-cell clone was also confirmed in uncultured, immunomagnetically isolated CD3+ (including CD3+/CD8−) cells.
Allospecific T-cell clones initiated either with CD3+/CD8− cells or with total PBMCs and subsequently identified by fluorescence-activated cell sorting (FACS) to be CD4+.
Allospecific T-cell clones initiated with CD8+ cells or with total PBMCs and subsequently identified by FACS to be CD8+.
Indicated is the number of primary T-cell clones with the specified genotypes.
This 996G>T clone was of CD4−/CD8− phenotype.